MedTrace Logo

Pilot Trial of Hibiscus Drink During Pregnancy (PTHDDP)

NCT07175597 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2025-09-16

No results posted yet for this study

Summary

The goal of this phase I pilot clinical trial is to evaluate the acceptability, tolerability and effect on blood pressure and biomarkers of Hibiscus sabdariffa drink in pregnant women in the second trimester of pregnancy. The main questions it aims to answer are:

Is the drink acceptable to take as a daily dose for a long time? Does drinking the beverage cause negative effects? What is the effect of drink consumption on blood pressure and biomarkers in pregnant women?

Each participant was their own control with the values measured before consumption of the beverage and after four weeks of consumption.

The participants:

* Took a daily dose of the beverage for 4 weeks
* Once a week for the four weeks, they answered the acceptability and tolerability questionnaires
* Before starting to consume the beverage and after the 4 weeks of consumption, they had their blood pressure measured, and samples taken for biomarker measurements.

Conditions

  • Pregnant Woman

Interventions

DIETARY_SUPPLEMENT

Hibiscus sabdariffa drink

A daily dose of Hibiscus sabdariffa drink that provides 9.6 mg of anthocyanins

Sponsors & Collaborators

  • National Polytechnic Institute, Mexico

    collaborator OTHER

  • Victor Eduardo Alcantar Rodríguez

    lead OTHER

Principal Investigators

  • Victor E. Alcantar Rodríguez, PhD Student · National Polytechnic Institute and Autonomous University of Barcelona

Study Design

Allocation
NA
Purpose
SCREENING
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-04-30
Primary Completion
2024-06-30
Completion
2025-06-30

Countries

  • Mexico

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07175597 on ClinicalTrials.gov